Clinical Trials on Parainfluenza Virus 3, Human
Total 7356 results
-
ViiV HealthcareGlaxoSmithKlineCompletedInfections, Human Immunodeficiency Virus and Herpesviridae
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus - Type 1United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, Chile, Malaysia, Panama, Romania, South Africa, Thailand, Brazil, Puerto Rico, Austria, Hungary, Australia, Guatemala
-
M.D. Anderson Cancer CenterCompletedHuman Immunodeficiency Virus InfectionsUnited States
-
Bristol-Myers SquibbCompletedHIV Infections | Human Immunodeficiency Virus Type 1 (HIV-1)United States, Netherlands
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
Kirby InstituteNational Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare and other collaboratorsWithdrawnCytomegalovirus Infections | Human Papilloma Virus | HIV-infection/Aids | Human Herpesvirus 4 Infections | Human Herpesvirus 8 Infection
-
Janssen Vaccines & Prevention B.V.CompletedInfluenza, Human Prevention | Respiratory Syncytial Viruses PreventionUnited States
-
Dove Medical Press LtdThe Affiliated Hospital of Qingdao UniversityCompletedBacterial Growth | Novel Influenza A (H1N1)China
-
Children's Hospital Medical Center, CincinnatiJohns Hopkins Bloomberg School of Public Health; Bill and Melinda Gates Foundation and other collaboratorsCompleted
-
Albert Einstein College of MedicineNational Institute of Mental Health (NIMH); HIV Center for Clinical & Behavioral...CompletedHuman Immunodeficiency Virus TransmissionUnited States
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID); New York University and other collaboratorsCompletedHIV (Human Immunodeficiency Virus)Swaziland
-
Janssen-Cilag International NVCompletedHuman Immunodeficiency Virus-type 1 InfectionSouth Africa, Kenya, Thailand, Uganda, Cameroon, Senegal
-
Merck Sharp & Dohme LLCCompletedHuman Immunodeficiency Virus-1 (HIV-1)
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus I
-
Vancouver Infectious Diseases CentreUnknownDrug Use | Human Immunodeficiency Virus I InfectionCanada
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedHuman Immunodeficiency Virus I InfectionBelgium
-
Columbia UniversityCompletedHIV (Human Immunodeficiency Virus)United States
-
Huntridge Family ClinicUnknownExposure to Human Immunodeficiency Virus (Event)United States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusArgentina
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, Peru, Romania, Colombia, South Africa, Germany, Russian Federation, Argentina, Mexico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IGermany, Spain, France, Australia, United States, Canada, United Kingdom, Italy, Russian Federation
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, France, Germany, Canada, Spain, United Kingdom, Mexico, Italy, Argentina, Chile, South Africa, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus IUnited States, Puerto Rico
-
Columbia UniversityMinistry of Health, SwazilandCompleted
-
Bristol-Myers SquibbMedarexCompletedHuman Immunodeficiency Virus (HIV)United States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusSpain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Mills Clinical ResearchViiV HealthcareUnknownInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineNo longer availableInfection, Human Immunodeficiency VirusBelgium, Russian Federation, Italy, South Africa, Argentina, Switzerland, Poland
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, France, Spain, Canada, Italy
-
Janssen PharmaceuticaWithdrawn
-
ViiV HealthcareGlaxoSmithKlineWithdrawnInfection, Human Immunodeficiency Virus IUnited States
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
-
ViiV HealthcareGlaxoSmithKlineWithdrawnInfection, Human Immunodeficiency VirusUnited States
-
Tibotec Pharmaceuticals, IrelandTibotec Pharmaceutical LimitedCompletedHuman Immunodeficiency Virus 1South Africa, Argentina, Brazil, India, Kenya
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedHuman Immunodeficiency Virus (HIV)United States, Puerto Rico
-
Janssen-Cilag S.p.A.CompletedHuman Immunodeficiency Virus; HIV
-
Georgetown UniversityGlaxoSmithKlineCompletedHuman Immunodeficiency Virus InfectionsUnited States
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1Germany